CN103394094B - 基于牛血清白蛋白-聚己内酯的高分子脂质体及其制备方法 - Google Patents
基于牛血清白蛋白-聚己内酯的高分子脂质体及其制备方法 Download PDFInfo
- Publication number
- CN103394094B CN103394094B CN201310298050.8A CN201310298050A CN103394094B CN 103394094 B CN103394094 B CN 103394094B CN 201310298050 A CN201310298050 A CN 201310298050A CN 103394094 B CN103394094 B CN 103394094B
- Authority
- CN
- China
- Prior art keywords
- preparation
- pcl
- bsa
- organic solvent
- lipidosome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001610 polycaprolactone Polymers 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000004632 polycaprolactone Substances 0.000 title claims abstract description 20
- 239000012888 bovine serum Substances 0.000 title abstract description 3
- 239000000839 emulsion Substances 0.000 claims abstract description 22
- 239000003960 organic solvent Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000008367 deionised water Substances 0.000 claims abstract description 13
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 13
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 11
- 229940098773 bovine serum albumin Drugs 0.000 claims abstract description 11
- 239000000523 sample Substances 0.000 claims abstract description 11
- 238000001704 evaporation Methods 0.000 claims abstract description 5
- 239000002502 liposome Substances 0.000 claims description 45
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- 238000010025 steaming Methods 0.000 claims description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 14
- 238000001338 self-assembly Methods 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 abstract description 12
- 229920002521 macromolecule Polymers 0.000 abstract description 6
- 239000002245 particle Substances 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 3
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 238000001132 ultrasonic dispersion Methods 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 description 9
- 239000006193 liquid solution Substances 0.000 description 9
- 239000003937 drug carrier Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000693 micelle Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 229920001400 block copolymer Polymers 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- -1 PTMC (PTMC) Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical class CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000005062 Polybutadiene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 229920001600 hydrophobic polymer Polymers 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920002857 polybutadiene Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229920000359 diblock copolymer Polymers 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- JGENYNHRIOHZOP-UHFFFAOYSA-N ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCOP([O-])(=O)OCC[N+](C)(C)C JGENYNHRIOHZOP-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 239000002539 nanocarrier Substances 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 108091008104 nucleic acid aptamers Proteins 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920002946 poly[2-(methacryloxy)ethyl phosphorylcholine] polymer Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310298050.8A CN103394094B (zh) | 2013-07-16 | 2013-07-16 | 基于牛血清白蛋白-聚己内酯的高分子脂质体及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310298050.8A CN103394094B (zh) | 2013-07-16 | 2013-07-16 | 基于牛血清白蛋白-聚己内酯的高分子脂质体及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103394094A CN103394094A (zh) | 2013-11-20 |
CN103394094B true CN103394094B (zh) | 2015-05-13 |
Family
ID=49557938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310298050.8A Active CN103394094B (zh) | 2013-07-16 | 2013-07-16 | 基于牛血清白蛋白-聚己内酯的高分子脂质体及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103394094B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104586769A (zh) * | 2014-12-29 | 2015-05-06 | 天津大学 | 基于白蛋白-高分子键合体的阿霉素高分子脂质体的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102697735A (zh) * | 2012-06-18 | 2012-10-03 | 南京大学医学院附属鼓楼医院 | 负载碱性抗肿瘤药物的高分子纳米粒子 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005298486A (ja) * | 2004-03-15 | 2005-10-27 | Nipro Corp | リポソームを含む癌治療用医薬組成物 |
US20120201873A1 (en) * | 2009-08-05 | 2012-08-09 | Pieris Ag | Controlled release formulations of lipocalin muteins |
-
2013
- 2013-07-16 CN CN201310298050.8A patent/CN103394094B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102697735A (zh) * | 2012-06-18 | 2012-10-03 | 南京大学医学院附属鼓楼医院 | 负载碱性抗肿瘤药物的高分子纳米粒子 |
Non-Patent Citations (1)
Title |
---|
牛血清白蛋白脂质体包封率的测定方法研究;侯冬枝 等;《药学学报》;20071231;第42卷(第5期);545-549页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103394094A (zh) | 2013-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Callahan et al. | Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution | |
Kang et al. | Tailoring the stealth properties of biocompatible polysaccharide nanocontainers | |
Ryu et al. | Self-cross-linked polymer nanogels: a versatile nanoscopic drug delivery platform | |
Vlassi et al. | Amphiphilic poly (2-oxazoline) copolymers as self-assembled carriers for drug delivery applications | |
Wang et al. | Self-assembled nanomaterials for photoacoustic imaging | |
Samarajeewa et al. | In vitro efficacy of paclitaxel-loaded dual-responsive shell cross-linked polymer nanoparticles having orthogonally degradable disulfide cross-linked corona and polyester core domains | |
CN104415338B (zh) | 主动靶向型抗肿瘤药物及其制备方法 | |
CA2486007A1 (en) | Delivery of nucleic acid-like compounds | |
Feng et al. | Host− Guest Chemistry of Dendrimer− Drug Complexes. 5. Insights into the Design of Formulations for Noninvasive Delivery of Heparin Revealed by Isothermal Titration Calorimetry and NMR Studies | |
CN103242517A (zh) | 多功能线性-树状嵌段共聚物的制备及其在药剂学中的应用 | |
Shen et al. | Self-assembly of core-polyethylene glycol-lipid shell (CPLS) nanoparticles and their potential as drug delivery vehicles | |
Shi et al. | Hemoglobin conjugated micelles based on triblock biodegradable polymers as artificial oxygen carriers | |
CN101422615A (zh) | 一种冬凌草甲素聚合物胶束给药制剂及制备方法 | |
Liu et al. | Extracellular stability of nanoparticulate drug carriers | |
Alcalá-Alcalá et al. | A biodegradable polymeric system for peptide–protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process | |
Yuan et al. | Micelle controlled release of 5-fluorouracil: Follow the guideline for good polymer–drug compatibility | |
Ren et al. | Red emissive carbon dots prepared from polymers as an efficient nanocarrier for coptisine delivery in vivo and in vitro | |
Feng et al. | Phenylboronic acid‐functionalized F127‐oligochitosan conjugate micelles for doxorubicin encapsulation | |
Gong et al. | pH-responsive cellulose-based microspheres designed as an effective oral delivery system for insulin | |
CN100368019C (zh) | 壳聚糖-海藻酸钠包裹幽门螺杆菌全菌蛋白微球及制备方法 | |
CN106496571B (zh) | 还原响应性两亲性嵌段聚合物及纳米胶束和应用 | |
Li et al. | Facile synthesis of a redox-responsive hyperbranched polymer prodrug as a unimolecular micelle for the tumor-selective drug delivery | |
CN106554425B (zh) | 一种聚唾液酸的脂质接枝衍生物及其应用 | |
Agrawal et al. | Multifunctional nanomedicines: potentials and prospects | |
Yoosefi et al. | Novel biodegradable molecularly imprinted polymer nanoparticles for drug delivery of methotrexate anti-cancer; synthesis, characterization and cellular studies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210907 Address after: Room 109, no.1866, Bohai 12th Road, Port Economic Zone, Binhai New Area, Tianjin 300452 Patentee after: Tianjin Bohua Xinchuang Technology Co.,Ltd. Address before: 300072 Tianjin City, Nankai District Wei Jin Road No. 92, Tianjin University Patentee before: Tianjin University |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20131120 Assignee: TIANJIN SHENGJI GROUP Co.,Ltd. Assignor: Tianjin Bohua Xinchuang Technology Co.,Ltd. Contract record no.: X2024980002161 Denomination of invention: Polymer liposomes based on bovine serum albumin polycaprolactone and their preparation method Granted publication date: 20150513 License type: Common License Record date: 20240222 |
|
OL01 | Intention to license declared | ||
OL01 | Intention to license declared |